海外の治験の状況「1」での検索結果
10032件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- Whether Use of Filter in intravenous line decreases the risk of aquiring sepsis in preterm neonates
- Preterm neonates
- India
- 2017-11-27
Not Recruiting
- Clinical study of apatinib combined with second - line chemotherapy for metastatic colorectal cancer
- colorectal cancer
- China
- 2018-01-16
Authorised
- Phase III study in first-line treatment of patients with metastatic colorectal cancer who are not candidate for intensive therapy
- Metastatic colorectal cancer MedDRA version: 20.0 Level: PT Classification code 10052358 Term: Colorectal cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Austria, Brazil, Bulgaria, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Netherlands, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Turkey, Ukraine, United Kingdom
- 2018-01-10
Not recruiting
- SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy
- Small-cell Lung Cancer
- China
- 2018-01-08
Not Recruiting
- Comparison of Levofloxacin based quadruple therapy with standard treatment in eradication of helicobacter pylori as first line Therapy
- Helicobacter Pylori infection. Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters;Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
- Iran (Islamic Republic of)
- 2018-01-03
Not recruiting
- An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck
- Head and Neck Cancer;Head and Neck Cancer;Head and Neck Cancer
- Argentina, Australia, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Germany, Italy, Japan, Korea, Republic of, Mexico, Poland, Romania, Russian Federation, Switzerland, Taiwan, Turkey, United Kingdom, United States
- 2017-12-22
Not recruiting
- First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)
- Esophageal Neoplasms
- Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Costa Rica, Denmark, France, Germany, Guatemala, Hong Kong, Japan, Korea, Republic of, Malaysia, Peru, Romania, Russian Federation, South Africa, Spain, Taiwan, Thailand, Turkey, United Kingdom, United States
- 2017-06-14
Authorised
- First-line Esophageal Carcinoma Study with Chemo vs. Chemo + Pembrolizumab
- First-line treatment of subjects with locally advanced unresectable or metastatic adenocarcinoma or squamous cell carcinoma of the esophagus or advanced/metastatic Siewert type 1 adenocarcinoma of the esophagogastric junction MedDRA version: 20.0 Level: LLT Classification code 10015366 Term: Esophageal carcinoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Costa Rica, Denmark, France, Germany, Guatemala, Hong Kong, Japan, Korea, Republic of, Malaysia, Peru, Romania, Russian Federation, South Africa, Spain, Taiwan, Thailand, Turkey, United Kingdom, United States
- 2017-04-11
Not Recruiting
- A DOUBLE-BLIND, RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDY TO COMPARE EFFICACY AND SAFETY OF CT-P16 AND EU-APPROVED AVASTIN AS FIRST-LINE TREATMENT FOR METASTATIC OR RECURRENT NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
- -C34 Malignant neoplasm of bronchus and lung Malignant neoplasm of bronchus and lung;Malignant neoplasm of bronchus and lung
- Belarus, Brazil, Bulgaria, Chile, Croatia, Georgia, Hungary, India, Japan, Korea South, Malasya, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Thailand, Ukraine, Vietnam
- 2018-12-31
Recruiting
- A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as First Line Treatment in Patients With Advanced Esophageal Squamous Cell Carcinoma
- Esophageal Squamous Cell Carcinoma (ESCC)
- Australia, Belgium, China, Czechia, France, Germany, Italy, Japan, Korea, Republic of, Poland, Romania, Russian Federation, Spain, Taiwan, United Kingdom, United States
- 2018-12-18
Not Recruiting
- Clinical study for second-line treatment of apatinib mesylate tablets in patients with advanced EGFR wild-type, non-squamous and non-small-cell lung cancer
- EGFR wild type, scale, non-small cell lung cancer
- China
- 2018-12-14
Not Recruiting
- Efficiency and safety of anlotinib hydrochloride plus SOX as first line therapy for advanced gastric cancer
- gastric cancer
- China
- 2018-12-12
Recruiting
- A single-arm phase II study for Anlotinib plus Docetaxel as a second-line therapy in patients with advanced non-small-cell lung cancer
- lung cancer;C34.900
- China
- 2018-12-11
Not Recruiting
- A prospective, positive, single-center, open clinical study for apatinib mesylate as first-line maintenance therapy for advanced pancreatic cancer
- pancreatic cancer
- China
- 2018-12-10
Not Recruiting
- Open, prospective, single-arm, multicenter clinical study for apatinib combined with first-line chemotherapy for stage III or IV ovarian, fallopian tube or primary peritoneal cancer
- ovarian cancer
- China
- 2018-11-30
Not Recruiting
- Evaluation of the Effect of Calcitriol on the Percutaneous Coronary Intervention
- Percutaneous coronary intervention (PCI). Atherosclerotic heart disease of native coronary artery with unstable angina pectoris;I25.110
- Iran (Islamic Republic of)
- 2018-11-30
Recruiting
- 1565nm non-ablative fractional laser in the treatment of periorbital fine lines: a prospective, self-controlled clinical trial
- periorbital fine lines
- China
- 2018-11-28
Recruiting
- Phase II trial, multicenter, first line Paclitaxel-Avelumab Treatment for inoperable Angiosarcoma
- ;Neoplasms
- Korea, Republic of
- 2018-11-09
Recruiting
- Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma
- Gastric, or Gastroesophageal Junction Adenocarcinoma
- China, France, Italy, Korea, Republic of, Poland, Puerto Rico, Romania, Russian Federation, Spain, Taiwan, Turkey, United States
- 2018-11-09
Recruiting
- Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC
- Non Small Cell Lung Cancer
- China
- 2018-11-08
